Wedbush Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.2M Sell
63,894
-1,354
-2% -$316K 0.42% 35
2026
Q1
$15.9M Buy
65,248
+618
+1% +$144K 0.47% 30
2025
Q4
$13.4M Buy
64,630
+3,860
+6% +$763K 0.39% 35
2025
Q3
$11.3M Buy
60,770
+6,638
+12% +$1.14M 0.37% 35
2025
Q2
$8.27M Sell
54,132
-3,650
-6% -$561K 0.29% 49
2025
Q1
$9.58M Buy
57,782
+991
+2% +$155K 0.35% 40
2024
Q4
$8.21M Buy
56,791
+1,244
+2% +$193K 0.29% 48
2024
Q3
$9M Sell
55,547
-8,940
-14% -$1.42M 0.33% 44
2024
Q2
$9.43M Sell
64,487
-2,847
-4% -$423K 0.34% 44
2024
Q1
$10.7M Buy
67,334
+6,956
+12% +$1.11M 0.4% 38
2023
Q4
$9.46M Buy
60,378
+143
+0.2% +$21.9K 0.42% 33
2023
Q3
$9.38M Sell
60,235
-2,425
-4% -$400K 0.47% 29
2023
Q2
$10.4M Sell
62,660
-6,109
-9% -$986K 0.49% 26
2023
Q1
$10.7M Buy
68,769
+3,114
+5% +$503K 0.53% 23
2022
Q4
$11.6M Sell
65,655
-5,077
-7% -$877K 0.64% 19
2022
Q3
$11.6M Buy
70,732
+836
+1% +$141K 0.65% 21
2022
Q2
$12.4M Buy
69,896
+759
+1% +$135K 0.68% 19
2022
Q1
$12.3M Buy
69,137
+3,373
+5% +$574K 0.56% 22
2021
Q4
$11.3M Sell
65,764
-4,649
-7% -$761K 0.48% 29
2021
Q3
$11.4M Sell
70,413
-57
-0.1% -$9.72K 0.54% 24
2021
Q2
$11.6M Sell
70,470
-1,067
-1% -$177K 0.55% 23
2021
Q1
$11.8M Buy
71,537
+14,695
+26% +$2.38M 0.65% 18
2020
Q4
$8.95M Buy
56,842
+5,545
+11% +$818K 0.78% 14
2020
Q3
$7.64M Sell
51,297
-1,441
-3% -$213K 0.73% 18
2020
Q2
$7.42M Buy
52,738
+2,610
+5% +$380K 0.7% 21
2020
Q1
$6.57M Buy
50,128
+1,257
+3% +$178K 0.78% 17
2019
Q4
$7.13M Sell
48,871
-3,484
-7% -$473K 0.63% 23
2019
Q3
$6.77M Sell
52,355
-1,268
-2% -$167K 0.66% 19
2019
Q2
$7.47M Buy
53,623
+274
+0.5% +$37.9K 0.75% 20
2019
Q1
$7.46M Buy
53,349
+2,325
+5% +$311K 0.8% 19
2018
Q4
$6.58M Buy
51,024
+10,506
+26% +$1.47M 0.84% 19
2018
Q3
$5.6M Buy
40,518
+2,310
+6% +$307K 0.64% 23
2018
Q2
$4.64M Buy
38,208
+4,707
+14% +$587K 0.57% 24
2018
Q1
$4.29M Sell
33,501
-12,007
-26% -$1.62M 0.56% 29
2017
Q4
$6.36M Buy
45,508
+1,841
+4% +$256K 0.78% 19
2017
Q3
$5.68M Sell
43,667
-1,940
-4% -$257K 0.74% 19
2017
Q2
$6.03M Buy
45,607
+1,721
+4% +$220K 0.78% 17
2017
Q1
$5.47M Sell
43,886
-378
-0.9% -$45.2K 0.74% 18
2016
Q4
$5.1M Sell
44,264
-2,332
-5% -$269K 0.75% 17
2016
Q3
$5.5M Sell
46,596
-1,579
-3% -$192K 0.82% 14
2016
Q2
$5.84M Sell
48,175
-219
-0.5% -$24.9K 0.96% 11
2016
Q1
$5.24M Buy
48,394
+2,823
+6% +$292K 0.91% 13
2015
Q4
$4.68M Buy
45,571
+2,405
+6% +$242K 0.85% 16
2015
Q3
$4.03M Buy
43,166
+304
+0.7% +$29.4K 0.81% 13
2015
Q2
$4.18M Sell
42,862
-270
-0.6% -$27K 0.77% 15
2015
Q1
$4.34M Sell
43,132
-3,647
-8% -$371K 0.74% 19
2014
Q4
$4.89M Buy
46,779
+389
+0.8% +$41K 0.75% 16
2014
Q3
$4.95M Buy
46,390
+263
+0.6% +$27.3K 0.77% 15
2014
Q2
$4.83M Sell
46,127
-2,842
-6% -$287K 0.77% 15
2014
Q1
$4.81M Buy
48,969
+7,215
+17% +$669K 0.84% 16
2013
Q4
$3.82M Buy
41,754
+774
+2% +$71.3K 0.9% 13
2013
Q3
$3.55M Buy
40,980
+455
+1% +$40.8K 0.94% 14
2013
Q2
$3.48M Buy
+40,525
New +$3.44M 0.95% 12

Other funds holding JNJ

Wedbush Securities's JNJ Position: Q2 2026 in Review

Wedbush Securities reduced its Johnson & Johnson (JNJ) stake by 2.1% in Q2 2026, selling an estimated $316K and leaving 63,894 shares worth $16.2M. The position accounts for 0.42% of the portfolio, ranked #35.

Wedbush Securities first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Wedbush Securities held 63,894 shares of Johnson & Johnson worth $16.2M as of Q2 2026.
  • Wedbush Securities sold 1,354 Johnson & Johnson shares in Q2 2026, an estimated $316K.
  • Johnson & Johnson made up 0.42% of Wedbush Securities's portfolio in Q2 2026, its #35 holding.
  • Wedbush Securities first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.